Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phase Genomics is a Seattle-based biotechnology company specializing in proximity ligation (Hi-C) technology to analyze the three-dimensional organization of genomes. The company's platform, ProxiMeta, enables high-resolution metagenomic assembly and the mapping of virus-host interactions (interactomes) without the need for laboratory culturing. Phase Genomics applies its technology across diverse fields, including oncology, where its OncoTerra platform detects chromosomal abnormalities in cancer, and infectious disease research, where it builds comprehensive phage-bacteria interactome atlases. By providing tools for advanced genome assembly and microbiome analysis, the company supports the discovery of novel therapeutics and the development of precision diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phage Genomics.